Company Profile
BLIS Technologies develops and sells probiotics in New Zealand, the Asia Pacific, Europe, the Middle East, Africa, and North America. It offers BLIS K12, an oral probiotic that supports ear, nose, and throat health, as well as immunity and bad breath.
Its portfolio also includes BLIS M18, an oral probiotic for teeth and gums health, and BLIS Q24, a probiotic that balances the skin microbiome and restores skin's health. Its products serve various health areas, including ear, nose, throat, immune, dental, and skin, as well as pet oral.
It exports its products. Incorporated in 2000 and headquartered in Dunedin, New Zealand, BLIS Technologies was formerly known as Tarn Holdings Limited before rebranding in August 2000.